Try our Advanced Search for more refined results
IN RE: Bayer Corp. Combination Aspirin Products Marketing and Sales Practices Litigation
Case Number:
1:09-md-02023
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Bartlit Beck
- Coughlin Midlige
- DLA Piper
- Douglas & London
- FeganScott
- Ford Law Firm LLP
- Fox Smith
- Hagens Berman
- Heidell Pittoni
- Heninger Garrison
- Kelley Drye
- Kolman Law
- Nealon Scialabba
- Niemeyer Grebel
- O'Leary Shelton
- Reed Smith
- Shindler Anderson
- Shook Hardy
Companies
Sectors & Industries:
-
May 17, 2012
Bayer Pays $15M To Soothe Consumers In Aspirin MDL
Bayer Corp. has agreed to pay $15 million to resolve class action claims that it misled consumers into believing its combination aspirin drugs had received regulatory approval, according to a settlement motion filed in New York federal court Wednesday.
-
September 16, 2009
Bayer Asks Court To Scrap MDL On Aspirin Marketing
Bayer Healthcare LLC has asked a federal judge in New York to scrap a multidistrict litigation case that accuses the pharmaceutical giant of illegally marketing its combination aspirins as a way to fend off heart and bone disease.
-
July 13, 2009
Aspirin Marketing MDL Bears Down on Bayer
Consumers accusing Bayer Healthcare LLC of promoting its aspirin products without regulatory approval have banded together in multidistrict litigation, filing a master complaint alleging the pharmaceutical giant illegally marketed its combination aspirins as a way to fend off heart and bone disease.